Divis Laboratories Q4 Results
- BSE: 532488
- NSE: DIVISLAB
- ISIN: INE361B01024
- Sector: Biotechnology & Drugs
BSE
6,990.00
58.20 (0.84%)
58.20 (0.84%)Volume4.59 K
Updated: Wed 9 Jul, 2025 | 15:29:00
NSE
6,983.5045.50 (0.66%)
45.50 (0.66%)Volume3.82 L
Updated: Wed 9 Jul, 2025 | 15:44:59
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹2,536.00 Cr.(10.12%)
- Operating Profit₹774.00 Cr.(21.32%)
- Profit After Tax₹667.00 Cr.(23.98%)
- Operating Margin30.52%(10.17%)
Note: Comparison is on YoY basis
Quarterly - Divis Laboratories Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 24 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1,762.00 | 1,675.00 | 5.19% | 1,665.00 | 5.83% |
| Depreciation/ Amortization | 107.00 | 99.00 | 8.08% | 95.00 | 12.63% |
| Operating Income | 774.00 | 644.00 | 20.19% | 638.00 | 21.32% |
| Net Income | 667.00 | 589.00 | 13.24% | 538.00 | 23.98% |
| Other Operating Expenses Total | 345.00 | 357.00 | -3.36% | 371.00 | -7.01% |
| Net Income Before Taxes | 861.00 | 726.00 | 18.60% | 713.00 | 20.76% |
| Total Revenue | 2,536.00 | 2,319.00 | 9.36% | 2,303.00 | 10.12% |
| Selling/ General/ Admin Expenses Total | 341.00 | 297.00 | 14.81% | 297.00 | 14.81% |
| Diluted Normalized EPS | 25.12 | 22.20 | 13.15% | 20.24 | 24.09% |